Emergence And Management Of Muti-Drug Resistant Pseudomonas Aeruginosa Isolated From Intensive-Care Unit

Authors

  • Saman Nadeem
  • Faisal Hanif
  • Yasmeen Taj
  • Sana Yousuf
  • Nadia Midhat Zehra
  • Pervaiz Asghar

DOI:

https://doi.org/10.51985/JBUMDC2018133

Keywords:

Antibiotic resistance pattern, Culture and sensitivity, Pseudomonas aeruginosa

Abstract

Objective: To evaluate the antibiotic resistance pattern of Pseudomonas aeruginosa and its prevalence from samples
received from Intensive Care Units (adult and neonatal) at PNS Shifa Hospital Karachi.
Study Design and Setting: This cross sectional study was carried out at PNS SHIFA hospital.
Methodology: Samples including blood, pus, wound swab, sputum and endobronchial washing were received for culture
and sensitivity. Isolates were cultured on blood and MacConkey agar. Antibiotic susceptibility testing was performed by
Kirby-Bauer and broth microdilution and then analyzed on SPSS version 23.Results were confirmed by VITEK 2.
Results: Out of 674 positive clinical specimens 97(14.39%) were positive for Pseudomonas aeruginosa growth. The most
susceptible antibiotic against Pseudomonas aeruginosa was Polymixin b (94.854%).The least effective antimicrobial was
aztreonam (40.21%sensitive).
Conclusion: The prevalence of Pseudomonas aeruginosa from the samples of Intensive Care Units was found to be 14.39%.
The most susceptible antibiotic against pseudomonas was Polymixin B. The least effective antimicrobial was aztreonam.

References

Patel H, Garala RN. Antibiotic susceptibility pattern of Pseudomonas aeruginosa isolated at SSG hospital Baroda. J Res Med Den Sci 2014;2:84-7.

Rouhi S, Ramazanzadeh R. Prevalence of bla (Oxacillinase-23)and bla(Oxacillinase-24/40-)type Carbapenemases in Pseudomonas aeruginosa Species Isolated From Patients With Nosocomial and Non-nosocomial Infections in the West of Iran. Iran J Pathol. 2018;13(3):348-356.

Sekhar M S, M K U, Rodrigues GS, Vyas N, Mukhopadhyay C. Antimicrobial susceptibility pattern of aerobes in diabetic foot ulcers in a South-Indian tertiary care hospital. Foot (Edinb) 2018;37:95-100.

Yusuf E, Van HB, Verbrugghe W, Leven M, Goovaerts E, Bergs K, et al. Emergence of antimicrobial resistance to Pseudomonas aeruginosa in the intensive care unit: association with the duration of antibiotic exposure and mode of administration. Ann Intensive Care. 2017;7(1):72.

Maraolo AE, Cascella M, Corcione S, Cuomo A, Nappa S, Borgia G, De Rosa FG, Gentile I.Management of multidrug-resistant Pseudomonas aeruginosa in theintensive care unit: state of the art.Expert Rev Anti Infect Ther.2017;15(9):861-71.

Clinical and Laboratory Standards institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. 27th ed. Wayne, PA: 2017.

Acharya M, Joshi PR, Thapa K, Aryal R, Kakshapati T, Sharma S. Detection of metallo-â-lactamases-encoding genes among clinical isolates of Pseudomonas aeruginosa in a tertiary care hospital, Kathmandu, Nepal. BMC Res Notes. 2017;10(1):718.

Kos VN, Déraspe M, McLaughlin RE, Whiteaker JD, Roy PH, Alm RA, Corbeil J, Gardner H. The resistome of Pseudomonas aeruginosa in relationship to phenotypic susceptibility. Antimicrob Agents Chemother. 2015;59(1):427-36.

Abbara S, Pitsch A, Jochmans S, Hodjat K, Cherrier DP, Monchi M, Vinsonneau C, Diamantis S. Impact of a multimodal strategy combining a new standard of care and restriction of carbapenems, fluoroquinolones and cephalosporins, on antibiotic consumption and resistance of P.aeruginosa in an ICU. Int J Antimicrob Agents. 2018;(18)30361-3.

Choudhury D, Ghose A, Dhar Chanda D, Das Talukdar A, Dutta Choudhury M, PaulD, Maurya AP, Chakravarty A, Bhattacharjee A. Premature Termination of MexR Lead to Overexpression of MexAB-OprM Efflux Pump in Pseudomonas aeruginosa in aTertiary Referral Hospital in India. PLoS One. 2016 ;11(2):e0149-156.

Al-Kabsi AM, Yusof MYBM, Sekaran SD. Antimicrobial resistance pattern of clinical isolates of Pseudomonas aeruginosa in the University of Malaya Medical Center, Malaysia. Afr J Microbiol Res 2011;5(29):5266-72.

Qureshi R, Shafique M, Shahid M, Rasool MH, Muzammil S. Molecular detection of blaVIM Metallo-â-lactamase producing clinically isolated Pseudomonas aeruginosa from tertiary care hospital, Faisalabad. Pak J Pharm Sci. 2018;31:2673-77.

Cho HH, Kwon GC, Kim S, Koo SH. Distribution of Pseudomonas-Derived Cephalosporinase and Metallo-â-Lactamases in Carbapenem-Resistant Pseudomonas aeruginosa Isolates from Korea. J Microbiol Biotechnol. 2015;25(7):1154-62.

Yin D, Wu S, Yang Y, Shi Q, Dong D, Zhu D, Hu F. In Vitro Activity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Clinical Isolates of Enterobacteriaceae and Pseudomonas aeruginosa: Results from a Multicenter Studym in China, 2017. Antimicrob Agents Chemother. 2019 Jan 7. pii: AAC.02431-18.

Samad A, Ahmed T, Rahim A, Khalil A, Ali I. Antimicrobial susceptibility patterns of clinical isolates of Pseudomonas aeruginosa isolated from patients o respiratory tract infections in a Tertiary Care Hospital, Peshawar. Pak J Med Sci. 2017;33(3):670-674.

Rashid A, Chowdhury A, Rahman SHZ, Begum SA, Muazzam N. Infections by Pseudomonas aeruginosa and antibiotic resistance pattern of the isolates from Dhaka Medical College Hospital. Bangladesh J Med Microbiol 2007;1(2):48-51.

Cai Y, Yang D, Wang J, Wang R. Amikacin and cefoperazone / sulbactam alone or incombination against carbapenem-resistant Pseudomonas aeruginosa. Diagn Microbiol Infect Dis. 2018;91(2):186-190.

Ahmad S, Harbi MNA. Antibiotic susceptibility pattern of isolates of Pseudomonas aeruginosa in a Saudi Arabian Hospital. BJMS 2014; 13:45-8.

Yamagishi Y, Hagihara M, Kato H, Hirai J, Nishiyama N, Koizumi Y, Sakanashi D,Suematsu H, Nakai H, Mikamo H. In vitro and in vivo Pharmacodynamics of Colistin and Aztreonam Alone and in Combination against Multidrug-Resistant Pseudomonas aeruginosa. Chemotherapy. 2017;62(2):105-110.

Radan M, Moniri R, Khorshidi A, Gilasi H, Norouzi Z, Beigi F, Dasteh Goli Y.Emerging Carbapenem-Resistant Pseudomonas aeruginosa Isolates Carrying bla(IMP)Among Burn Patients in Isfahan, Iran. Arch Trauma Res. 2016;5(3):e33664.

Jorth P, McLean K, Ratjen A, Secor PR, Bautista GE, Ravishankar S, Rezayat A, Garudathri J, Harrison JJ, Harwood RA, Penewit K, Waalkes A, Singh PK, Salipante SJ. Evolved Aztreonam Resistance Is Multifactorial and Can Produce Hypervirulence in Pseudomonas aeruginosa. MBio. 2017 ;8(5). pii: e00517-17.

Karlowsky JA, Kazmierczak KM, de Jonge BLM, Hackel MA, Sahm DF, Bradford PA. In Vitro Activity of Aztreonam-Avibactam against Enterobacteriaceae and Pseudomonas aeruginosa Isolated by Clinical Laboratories in 40 Countries from 2012 to 2015. Antimicrob Agents Chemother. 2017;61(9). pii: e00472-17.

Downloads

Published

2019-06-05

How to Cite

Nadeem, S. ., Hanif, F. ., Taj, Y. ., Yousuf, S. ., Zehra, N. M. ., & Asghar, P. . (2019). Emergence And Management Of Muti-Drug Resistant Pseudomonas Aeruginosa Isolated From Intensive-Care Unit. Journal of Bahria University Medical and Dental College, 9(2), 137–140. https://doi.org/10.51985/JBUMDC2018133

Issue

Vol. 9 No. 2 (2019): Volume 9 Issue 2

Section

Original Articles

License

Copyright (c) 2019 Saman Nadeem, Faisal Hanif, Yasmeen Taj, Sana Yousuf, Nadia Midhat Zehra, Pervaiz Asghar

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Journal of Bahria University Medical & Dental College is an open access journal and is licensed under CC BY-NC 4.0. which permits unrestricted non commercial use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc/4.0

Most read articles by the same author(s)